Discovering, developing and advancing diagnosis, new medicines and treatments for patients

The Leicester Precision Medicine Institute (LPMI) brings together the research expertise and facilities of the University of Leicester and University Hospitals Leicester NHS Trust with industry to advance new medicines and medical technology innovations to impact on healthcare in our multi-ethnic population.

Integration of new technologies is providing much more information about health and disease that we are using to better predict, diagnose and treat disease. Through LPMI partners we are ensuring more rapid delivery of improved healthcare to our patients in the UHL NHS trust, the wider UK and the world.

We will be adding to our website over the next few weeks, please come back to visit us. If you have any enquires please contact us at

LPMI About Us LPMI research areas

LPMI Working with Industry LPMI Team

Share this page:


Latest funding opportunity from Office of Life Sciences and Innovate UK

The funding competition SME support to evaluate innovative medical technologies: round 2 opened for applications 02 July 2018. SMEs can apply for a share of £1.5 million to support the evaluation, in a real world clinical setting, of innovative medical devices, diagnostics and regulated digital health products that address NHS priorities.

Key details to consider in potential partnering:

  •  For each grant award there can only be a single grant claimant and they must be an SME
  • Any work carried out by universities or NHS is on a subcontracted basis (not as a collaborative partner)
  • Eligible products must be CE marked before the application is made
  • The product must be available for sale in the UK before the application is made
  • The product cannot have been marketed in the UK for more than 5 years
  • Application deadline is 22 August 2018, 12:00pm


 Professor Karen Brown, talks about tamoxifen and breast cancer prevention on BBC radio 4 Inside Health


 Annual Frank May Prize Lecture

Speaker: Professor Gerry McCann Title: ‘Using MRI to better understand and manage heart disease’More details and  registration here


'A new early detection blood test for 10 types of cancer could be used to screen for the disease before symptoms appear' LPMI director Prof. Jacqui Shaw is featured in a news article in the Guardian


Up to £5m funding available - Manufacturing readiness and scale up of genomic analysis technologies - innovate uk's 2nd competition under the ISCF Challenge “Data to Early Diagnosis and Precision Medicine”


Listen to our Director Prof. Jacqui Shaw on the BBC World Service discussing the latest news on a blood test to detect 10 different cancers


Prof. Jacqui Shaw talks about the important role of liquid biopsies in cancer at the World Precision Medicine Congress


More LPMI News Here
For LPMI Enquiries:

Professor Jacqui Shaw

Dr Ruth Barber

Dr Michael Sullivan

Dr Carl Edwards

Dr Riddhi Shukla


t: +44 (0)116 223 1594